Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

GlaxoSmithKline Pharmaceuticals Limited (GLAXO.BO)

BSE - BSE Real Time Price. Currency in INR
Add to watchlist
1,471.10+2.40 (+0.16%)
At close: 3:29PM IST
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close1,468.70
Open1,470.00
Bid1,460.00 x 0
Ask1,468.90 x 0
Day's Range1,460.00 - 1,471.70
52 Week Range1,046.40 - 1,805.00
Volume1,600
Avg. Volume3,592
Market Cap249.213B
Beta (5Y Monthly)N/A
PE Ratio (TTM)275.38
EPS (TTM)N/A
Earnings DateJul 29, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1,238.59
  • Motley Fool

    Investing $100,000 in These 3 Dividend Stocks Could Give You Annual Income of $7,700

    The closer you get to retirement, dividend income will rank higher among your investing objectives. Many dividend stocks won't provide all that much income each year. Investing $100,000 spread across these three dividend stocks could give you added income of close to $7,700 per year.

  • Bloomberg

    23andMe Expands Into Telehealth Care With Lemonaid Purchase

    (Bloomberg) -- Consumer DNA testing giant 23andMe Holding Co. agreed to purchase telehealth upstart and drug-delivery service Lemonaid Health Inc. in a bid to make its personalized genetics approach part of patients’ primary care. Most Read from BloombergThe Top Money Maker at Deutsche Bank Reaps Billions From SingaporeWhy Americans and Britons Are Rushing to Buy Idyllic Homes in ItalyCities' Answer to Sprawl? Go Wild.Forget Palm Springs—Santa Fe Is the New Mecca for Modern ArchitectureOne of Ca

  • Motley Fool

    Why 23andMe Stock Has Jumped 16% So Far This Week

    What happened Shares of the genetic-testing company 23andMe (NASDAQ: ME) gained another 16% through Thursday's close this week, according to data from S&P Global Market Intelligence. The biotech's stock is now up by more than 34% over the past two weeks.

Advertisement
Advertisement